149 related articles for article (PubMed ID: 19766967)
1. Chapter 2. Calcineurin signaling and the slow oxidative skeletal muscle fiber type.
Mallinson J; Meissner J; Chang KC
Int Rev Cell Mol Biol; 2009; 277():67-101. PubMed ID: 19766967
[TBL] [Abstract][Full Text] [Related]
2. Matching of calcineurin activity to upstream effectors is critical for skeletal muscle fiber growth.
Dunn SE; Chin ER; Michel RN
J Cell Biol; 2000 Oct; 151(3):663-72. PubMed ID: 11062266
[TBL] [Abstract][Full Text] [Related]
3. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.
Quinn LS; Anderson BG; Plymate SR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1538-51. PubMed ID: 17940216
[TBL] [Abstract][Full Text] [Related]
4. Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted mice.
Parsons SA; Wilkins BJ; Bueno OF; Molkentin JD
Mol Cell Biol; 2003 Jun; 23(12):4331-43. PubMed ID: 12773574
[TBL] [Abstract][Full Text] [Related]
5. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type.
Wu H; Naya FJ; McKinsey TA; Mercer B; Shelton JM; Chin ER; Simard AR; Michel RN; Bassel-Duby R; Olson EN; Williams RS
EMBO J; 2000 May; 19(9):1963-73. PubMed ID: 10790363
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin signaling and neural control of skeletal muscle fiber type and size.
Schiaffino S; Serrano A
Trends Pharmacol Sci; 2002 Dec; 23(12):569-75. PubMed ID: 12457775
[TBL] [Abstract][Full Text] [Related]
7. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.
Delling U; Tureckova J; Lim HW; De Windt LJ; Rotwein P; Molkentin JD
Mol Cell Biol; 2000 Sep; 20(17):6600-11. PubMed ID: 10938134
[TBL] [Abstract][Full Text] [Related]
8. Ca
Luo P; Wang L; Luo L; Wang L; Yang K; Shu G; Wang S; Zhu X; Gao P; Jiang Q
Food Funct; 2019 Aug; 10(8):5166-5173. PubMed ID: 31378798
[TBL] [Abstract][Full Text] [Related]
9. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy.
Parsons SA; Millay DP; Wilkins BJ; Bueno OF; Tsika GL; Neilson JR; Liberatore CM; Yutzey KE; Crabtree GR; Tsika RW; Molkentin JD
J Biol Chem; 2004 Jun; 279(25):26192-200. PubMed ID: 15082723
[TBL] [Abstract][Full Text] [Related]
10. Roles of the calcineurin and CaMK signaling pathways in fast-to-slow fiber type transformation of cultured adult mouse skeletal muscle fibers.
Mu X; Brown LD; Liu Y; Schneider MF
Physiol Genomics; 2007 Aug; 30(3):300-12. PubMed ID: 17473216
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development.
Schulz RA; Yutzey KE
Dev Biol; 2004 Feb; 266(1):1-16. PubMed ID: 14729474
[TBL] [Abstract][Full Text] [Related]
12. Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling.
Chakkalakal JV; Stocksley MA; Harrison MA; Angus LM; Deschenes-Furry J; St-Pierre S; Megeney LA; Chin ER; Michel RN; Jasmin BJ
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7791-6. PubMed ID: 12808150
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo.
Naya FJ; Mercer B; Shelton J; Richardson JA; Williams RS; Olson EN
J Biol Chem; 2000 Feb; 275(7):4545-8. PubMed ID: 10671477
[TBL] [Abstract][Full Text] [Related]
14. Myospryn is a calcineurin-interacting protein that negatively modulates slow-fiber-type transformation and skeletal muscle regeneration.
Kielbasa OM; Reynolds JG; Wu CL; Snyder CM; Cho MY; Weiler H; Kandarian S; Naya FJ
FASEB J; 2011 Jul; 25(7):2276-86. PubMed ID: 21427212
[TBL] [Abstract][Full Text] [Related]
15. Parallel mechanisms for resting nucleo-cytoplasmic shuttling and activity dependent translocation provide dual control of transcriptional regulators HDAC and NFAT in skeletal muscle fiber type plasticity.
Shen T; Liu Y; Randall WR; Schneider MF
J Muscle Res Cell Motil; 2006; 27(5-7):405-11. PubMed ID: 16874450
[TBL] [Abstract][Full Text] [Related]
16. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins.
Frey N; Richardson JA; Olson EN
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14632-7. PubMed ID: 11114196
[TBL] [Abstract][Full Text] [Related]
17. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
[TBL] [Abstract][Full Text] [Related]
18. Remodeling muscles with calcineurin.
Olson EN; Williams RS
Bioessays; 2000 Jun; 22(6):510-9. PubMed ID: 10842305
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic analysis of the calcineurin signaling pathways.
Sugiura R; Sio SO; Shuntoh H; Kuno T
Cell Mol Life Sci; 2001 Feb; 58(2):278-88. PubMed ID: 11289309
[TBL] [Abstract][Full Text] [Related]
20. The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling.
Dierck F; Kuhn C; Rohr C; Hille S; Braune J; Sossalla S; Molt S; van der Ven PFM; Fürst DO; Frey N
J Biol Chem; 2017 Sep; 292(37):15180-15191. PubMed ID: 28717008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
